1. Home
  2. EMBC vs BZH Comparison

EMBC vs BZH Comparison

Compare EMBC & BZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EMBC
  • BZH
  • Stock Information
  • Founded
  • EMBC 1924
  • BZH 1985
  • Country
  • EMBC United States
  • BZH United States
  • Employees
  • EMBC N/A
  • BZH N/A
  • Industry
  • EMBC Medical/Dental Instruments
  • BZH Homebuilding
  • Sector
  • EMBC Health Care
  • BZH Consumer Discretionary
  • Exchange
  • EMBC Nasdaq
  • BZH Nasdaq
  • Market Cap
  • EMBC 788.4M
  • BZH 780.6M
  • IPO Year
  • EMBC N/A
  • BZH 1994
  • Fundamental
  • Price
  • EMBC $15.23
  • BZH $26.17
  • Analyst Decision
  • EMBC Buy
  • BZH Strong Buy
  • Analyst Count
  • EMBC 2
  • BZH 3
  • Target Price
  • EMBC $18.50
  • BZH $32.00
  • AVG Volume (30 Days)
  • EMBC 488.5K
  • BZH 388.4K
  • Earning Date
  • EMBC 08-08-2025
  • BZH 11-12-2025
  • Dividend Yield
  • EMBC 3.98%
  • BZH N/A
  • EPS Growth
  • EMBC 18.26
  • BZH N/A
  • EPS
  • EMBC 1.42
  • BZH 2.23
  • Revenue
  • EMBC $1,102,500,000.00
  • BZH $2,385,816,000.00
  • Revenue This Year
  • EMBC N/A
  • BZH N/A
  • Revenue Next Year
  • EMBC N/A
  • BZH $6.03
  • P/E Ratio
  • EMBC $10.62
  • BZH $11.66
  • Revenue Growth
  • EMBC N/A
  • BZH 9.97
  • 52 Week Low
  • EMBC $9.20
  • BZH $17.37
  • 52 Week High
  • EMBC $21.48
  • BZH $38.22
  • Technical
  • Relative Strength Index (RSI)
  • EMBC 66.50
  • BZH 57.73
  • Support Level
  • EMBC $14.92
  • BZH $25.31
  • Resistance Level
  • EMBC $15.44
  • BZH $26.49
  • Average True Range (ATR)
  • EMBC 0.50
  • BZH 0.74
  • MACD
  • EMBC -0.08
  • BZH 0.01
  • Stochastic Oscillator
  • EMBC 84.31
  • BZH 65.22

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

About BZH Beazer Homes USA Inc.

Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in over 13 states and over 22 metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the leading sources of revenue for the company. Key metro areas include Atlanta, Las Vegas, Los Angeles, Orlando, and Tampa. The company also focuses on land purchasing and development to support future construction efforts as well as mortgage services for its homebuyers.

Share on Social Networks: